{"id":"https://openalex.org/W2609052001","doi":null,"title":"Revista Brasileira de Psiquiatria","display_name":"Revista Brasileira de Psiquiatria","publication_year":2012,"publication_date":"2012-01-01","ids":{"openalex":"https://openalex.org/W2609052001","mag":"2609052001"},"language":"es","primary_location":{"id":"mag:2609052001","doi":null,"is_oa":false,"landing_page_url":"http://www.scielo.br/pdf/rbp/v34n1/v34n1a21.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5087819650","display_name":"Francisco Jos\u00e9 Roma Paumgartten","orcid":"https://orcid.org/0000-0002-6207-0149","observed_orcids":["https://orcid.org/0000-0002-6207-0149"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Francisco Jos\u00e9 Roma Paumgartten","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-6207-0149","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110286741","display_name":"Escola Nacional de Sa\u00fade","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Escola Nacional de Sa\u00fade","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5053786901","display_name":"Renz Cl","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Renz Cl","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12539","display_name":"Pharmacology and Obesity Treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12539","display_name":"Pharmacology and Obesity Treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11649","display_name":"Pharmaceutical industry and healthcare","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2910","display_name":"Issues, ethics and legal aspects"},"field":{"id":"https://openalex.org/fields/29","display_name":"Nursing"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sibutramine","display_name":"sibutramine","score":1.0},{"id":"https://openalex.org/keywords/cardiovascular-safety","display_name":"cardiovascular safety","score":0.5870000123977661},{"id":"https://openalex.org/keywords/weight-loss","display_name":"weight loss","score":0.6800000071525574},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.8479999899864197},{"id":"https://openalex.org/keywords/obesity","display_name":"obesity","score":0.7009999752044678},{"id":"https://openalex.org/keywords/risk-benefit-assessment","display_name":"risk-benefit assessment","score":0.746999979019165},{"id":"https://openalex.org/keywords/anvisa","display_name":"ANVISA","score":0.5550000071525574},{"id":"https://openalex.org/keywords/fda","display_name":"FDA","score":0.4410000145435333},{"id":"https://openalex.org/keywords/ema","display_name":"EMA","score":0.9559999704360962},{"id":"https://openalex.org/keywords/cardiovascular-morbidity","display_name":"cardiovascular morbidity","score":0.5649999976158142}],"concepts":[{"id":"https://openalex.org/C2777646958","wikidata":"https://www.wikidata.org/wiki/Q424151","display_name":"Sibutramine","level":4,"score":0.9798227548599243},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7473936080932617},{"id":"https://openalex.org/C544821477","wikidata":"https://www.wikidata.org/wiki/Q718113","display_name":"Weight loss","level":3,"score":0.6502107381820679},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.5916992425918579},{"id":"https://openalex.org/C511355011","wikidata":"https://www.wikidata.org/wiki/Q12174","display_name":"Obesity","level":2,"score":0.5010964870452881},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.4645848572254181},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.45302364230155945},{"id":"https://openalex.org/C108170787","wikidata":"https://www.wikidata.org/wiki/Q3951828","display_name":"Agency (philosophy)","level":2,"score":0.4314464032649994},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.2553982734680176},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.25006499886512756},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.0810108482837677},{"id":"https://openalex.org/C111472728","wikidata":"https://www.wikidata.org/wiki/Q9471","display_name":"Epistemology","level":1,"score":0.0},{"id":"https://openalex.org/C138885662","wikidata":"https://www.wikidata.org/wiki/Q5891","display_name":"Philosophy","level":0,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2609052001","doi":null,"is_oa":false,"landing_page_url":"http://www.scielo.br/pdf/rbp/v34n1/v34n1a21.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":1,"referenced_works":["https://openalex.org/W2119779723"],"related_works":["https://openalex.org/W2004247064","https://openalex.org/W2160666094","https://openalex.org/W2123530223","https://openalex.org/W1992922546","https://openalex.org/W2022326362","https://openalex.org/W2087648507","https://openalex.org/W2059693930","https://openalex.org/W7096372410","https://openalex.org/W4245260571","https://openalex.org/W2025150013"],"abstract_inverted_index":{"2commented":[0],"that":[1,10,17,34,50,59,241,262],"SCOUT":[2,132,215,242],"studied":[3],"a":[4,126,177,194,204,234,245],"population":[5,195],"remarkably":[6],"different":[7],"from":[8,168,201],"patients":[9,138,153,197,228,248],"use":[11],"sibutramine":[12,223],"in":[13,26,137,160,182,227,273],"daily":[14],"life":[15],"and":[16,43,49,86,90,112,118,142,185,232,255],"most":[18],"participants":[19,243],"did":[20,145,266],"not":[21,146,267],"meet":[22],"treatment":[23],"criteria":[24],"specified":[25],"the":[27,57,66,83,91,98,110,135,155,165,169,174,208,212,280],"drug":[28,175],"label.":[29],"The":[30,73,214],"authors":[31],"also":[32,260],"stated":[33],"\u201cbenefits":[35],"of":[36,97,106,114,152,157,173,196,247,276],"weight":[37,158,221,264],"loss\u201d":[38],"were":[39,244],"dismissed":[40],"by":[41,56,82],"FDA":[42],"EMA":[44],"as":[45],"an":[46,103],"efficacy":[47,113],"criterion":[48],"risk-benefit":[51],"balance":[52],"was":[53],"apparently":[54],"biased":[55],"idea":[58],"\u201ctoo":[60],"many":[61],"individuals":[62],"would":[63,163],"be":[64],"using":[65],"medication":[67],"merely":[68],"for":[69,124,206,252],"cosmetic":[70],"reasons\u201d.":[71],"2":[72],"aforementioned":[74],"interpretation":[75],"is":[76,239,259],"at":[77,249],"odds":[78],"with":[79,139,229],"conclusions":[80],"reached":[81],"American":[84],"(FDA)":[85],"European":[87],"(EMA)":[88],"agencies":[89],"Advisory":[92],"Committee":[93],"on":[94,109],"Medicines":[95],"(CATEME)":[96],"Brazilian":[99],"agency":[100],"(ANVISA).":[101],"After":[102],"extensive":[104],"analysis":[105],"available":[107],"data":[108],"safety":[111],"sibutramine,":[115],"FDA,":[116],"EMA,":[117],"CATEME":[119],"found":[120],"no":[121,190],"scientific":[122],"basis":[123],"adopting":[125],"risk":[127,166,251],"mitigation":[128],"strategy.":[129],"First,":[130],"because":[131,189],"data,":[133],"given":[134],"overlap":[136],"obesity,":[140],"diabetes,":[141],"cardiovascular":[143,161,171,225,236,271],"risk,":[144],"reveal":[147],"any":[148],"point":[149],"or":[150,233,269],"subpopulation":[151],"where":[154],"benefit":[156,200],"loss":[159,265],"morbidity":[162,226,272],"exceed":[164],"arising":[167],"intrinsic":[170],"effect":[172],"(e.g.,":[176],"small":[178],"but":[179],"sustained":[180],"rise":[181],"blood":[183],"pressure":[184],"heart":[186,253],"rate).":[187],"Second,":[188],"study":[191],"has":[192],"defined":[193],"who":[198],"may":[199],"sibutramine;":[202],"i.e,":[203],"group":[205,275],"whom":[207],"benefits":[209],"clearly":[210],"outweigh":[211],"risks.":[213],"showed":[216],"that,":[217],"while":[218],"causing":[219],"some":[220],"reduction,":[222],"increased":[224],"type-2":[230],"diabetes":[231],"higher":[235,250],"risk.":[237],"It":[238],"obvious":[240],"subgroup":[246],"attacks":[254],"strokes.":[256],"Nonetheless,":[257],"it":[258],"clear":[261],"sibutramine-caused":[263],"prevent":[268],"ameliorate":[270],"this":[274],"patients.":[277],"Letter":[278],"to":[279],"Editors":[281]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2017-05-05T00:00:00"}